GI Advantage

product on market Capsule 1st Phorm 🟢 Safety: 100/100
Brand: 1st Phorm
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 44% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
44% Evidence Coverage

Supplement Facts — Evidence Check

0.86 mg (8% DV)
✅ Within RDA (0.1× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 0.86mg UL 40mg
750 mg
📊 Market median: 420.0mg (227 products)
Median 420.0mg This product: 750mg
400 mg
📊 Market median: 420.0mg (127 products) 📚 1 studies (Tier A: 0, B: 1)
This product: 400mg
400 mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 400mg
Slippery Elm bark powder
400 mg
Galactoarabinan
250 mg
Dimethylglycine HCl
125 mg
62.5 mg
📊 Market median: 100.0mg (166 products) 📚 10 studies (Tier A: 0, B: 1)
This product: 62.5mg
Marshmallow Root Extract
25 mg

Other Ingredients

Rice Flour Microcrystalline Cellulose Magnesium Stearate Hypromellose

Label Claims — Verification

❓ Structure/Function
All Other (99% of products) Structure/Function (84% of products) Nutrient (48% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

🧪 Formulation Notes

Foundation Series Premium comprehensive gastrointestinal system formula Reduce heartburn Decrease gut inflammation Optimize digestion

Additional Information

Nothing compares

Product Details

DSLD Entry Date 2021-03-25
Product Type Other Combinations
Form Capsule
Brand 1st Phorm
DSLD ID 242777
Data Updated 2026-04-11

Research Evidence

397 Research Sources
55 Avg Quality Score
200 Meta Analysis
68 Rct
58 Systematic Review
53 Clinical Trial
9 Cochrane Review
2 Narrative Review
2 Regulatory Source
1 Observational
1 Other
1 Openfda Safety
A Zinc supplementation for improving pregnancy and infant outcome
Meta Analysis The Cochrane database of systematic reviews 2021
PubMed DOI Cochrane
A Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Narrative Review The Cochrane database of systematic reviews 2023
PubMed DOI Cochrane
A Oral zinc for treating diarrhoea in children
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2021
PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2010
PubMed DOI Cochrane
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI Cochrane
A Compression bandages or stockings versus no compression for treating venous leg ulcers
Meta Analysis The Cochrane database of systematic reviews 2021
PubMed DOI
A Zinc supplementation for mental and motor development in children
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI Cochrane
A Zinc for the common cold
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI
View all evidence for Zinc →

Compare Similar Products

Zinc Picolinate 30 mg VitaCeutical Labs 100
Opti-Zinc 30 Douglas Laboratories 100
Zinc Picolinate Cardiovascular Research 100
Zinc Picolinate 25 mg Kirkman 100
Zinc 20 mg Kirkman 100
View all Zinc products →
Zinc research & evidence Best Zinc rankings All Zinc products More from 1st Phorm View on NIH DSLD →